Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 21:11:1487443.
doi: 10.3389/fmed.2024.1487443. eCollection 2024.

The diagnostic and prognostic value of soluble ST2 in Sepsis

Affiliations

The diagnostic and prognostic value of soluble ST2 in Sepsis

Xinghua Ye et al. Front Med (Lausanne). .

Abstract

Objective: To determine the diagnostic and prognostic value of soluble suppression of tumorigenicity 2 (sST2) in patients with sepsis.

Methods: A total of 113 critically ill patients were enrolled at the emergency department of Beijing Chaoyang Hospital Jing Xi Branch. Venous blood levels of sST2 were measured using the AFIAS-6 dry fluorescence immunoassay analyzer. Based on Sepsis 3.0 criteria, patients were categorized into a sepsis group (76 cases) and a non-sepsis group (37 cases). The sepsis group was further divided into non-survivors (38 cases) and survivors (38 cases) based on 28-day survival outcomes. The vital signs, blood gas analysis, routine blood tests, liver and kidney function tests, procalcitonin (PCT), C-reactive protein (CRP), sST2, left ventricular ejection fraction (LVEF), and other basic characteristics of the patients were recorded. Further, the SOFA, qSOFA and APACHE II scores of each patient were calculated. Statistical analysis was performed using SPSS 25.0, including logistic regression and ROC curve analysis to assess prognostic factors.

Results: The serum sST2 levels in the sepsis group (125.00 ± 60.32 ng/mL) were significantly higher than in the non-sepsis group (58.55 ± 39.03 ng/mL) (p < 0.05). The SOFA score (8.08 ± 2.88), APACHE II score (18.00 ± 4.72), blood sST2 levels (168.06 ± 36.75 ng/mL) and lactic acid levels (2.89 ± 3.28) in the non-survivor group were significantly higher than the survivor group (p < 0.05). Multiple logistic regression analysis showed that sST2, SOFA score, APACHE II score and lactic acid levels were independent risk factors for poor prognosis in patients with sepsis. The ROC curve analysis of the above indexes showed no significant differences between the AUC of sST2 (0.912) and the SOFA score (0.929) (z = 0.389, p = 0.697), or the APACHE II score (0.933) (z = 0.484, p = 0.627). However, there was a significant difference between the AUC of sST2 (0.912) and lactic acid levels (0.768) (z = 2.153, p = 0.030).

Conclusion: Blood levels of sST2 show a clinically diagnostic and prognostic value in sepsis. Further, sST2 shows a similar predictive ability as the SOFA and APACHE II scores in determining the prognosis of sepsis patients. However, sST2 has a higher predictive ability than lactic acid levels in determining prognosis in sepsis.

Keywords: APACHE II score; SOFA score; Sepsis; diagnosis; lactic acid; prognosis; soluble ST2.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The flowchart of the patient screening process.
Figure 2
Figure 2
ROC curve of the SOFA score, sST2, APACHE II score and lactic acid levels on the prediction of mortality. ROC curve, receiver operating characteristic curve; SOFA score, sequential organ failure assessment score. sST2, soluble suppression of tumorigenicity 2; APACHE II, acute physiology and chronic health evaluation II.
Figure 3
Figure 3
ROC curve showing the predictive value of combining SOFA with sST2 and APACHE II with sST2 for mortality prediction. ROC curve, receiver operating characteristic curve; SOFA score, sequential organ failure assessment score. sST2, soluble suppression of tumorigenicity 2; APACHE II, acute physiology and chronic health evaluation II.

Similar articles

References

    1. Zampieri FG, Bagshaw SM, Semler MW. Fluid therapy for critically ill adults with Sepsis: a review. JAMA. (2023) 329:1967–80. doi: 10.1001/jama.2023.7560, PMID: - DOI - PubMed
    1. Santacroce E, D’Angerio M, Ciobanu AL, Masini L, Lo Tartaro D, Coloretti I, et al. . Advances and challenges in Sepsis management: modern tools and future directions. Cells. (2024) 13:13. doi: 10.3390/cells13050439, PMID: - DOI - PMC - PubMed
    1. Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov. (2008) 7:827–40. doi: 10.1038/nrd2660, PMID: - DOI - PMC - PubMed
    1. Homsak E, Gruson D. Soluble ST2: a complex and diverse role in several diseases. Clinica Chimica Acta. (2020) 507:75–87. doi: 10.1016/j.cca.2020.04.011, PMID: - DOI - PubMed
    1. Kotsiou OS, Gourgoulianis KI, Zarogiannis SG. IL-33/ST2 Axis in organ fibrosis. Front Immunol. (2018) 9:2432. doi: 10.3389/fimmu.2018.02432, PMID: - DOI - PMC - PubMed

LinkOut - more resources